{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:27:28Z","timestamp":1787678848683,"version":"build-2784847793"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002753","name":"Universidad Nacional de Colombia","doi-asserted-by":"publisher","award":["58990"],"award-info":[{"award-number":["58990"]}],"id":[{"id":"10.13039\/501100002753","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022965","name":"Ministerio de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022965","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003033","name":"Ministerio de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2021-126310OA-I00"],"award-info":[{"award-number":["PID2021-126310OA-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Carbohydrate Polymers"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.carbpol.2024.122930","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T02:09:28Z","timestamp":1730254168000},"page":"122930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"PB","title":["Heparin-azithromycin microparticles show anti-inflammatory effects and inhibit SARS-CoV-2 and bacterial pathogens associated to lung infections"],"prefix":"10.1016","volume":"348","author":[{"given":"Brayan J.","family":"Anaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"D'Angelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruggero","family":"Bettini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gracia","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amadeo","family":"Sanz-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Auxiliadora","family":"Dea-Ayuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Galiana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmina","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego F.","family":"Tirado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Lalatsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Gonz\u00e1lez-Burgos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores R.","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.carbpol.2024.122930_bb0005","doi-asserted-by":"crossref","first-page":"493","DOI":"10.15585\/mmwr.mm7218a4","article-title":"COVID-19 mortality update - United States, 2022","volume":"72","author":"Ahmad","year":"2023","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"8","key":"10.1016\/j.carbpol.2024.122930_bb0010","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa1104623","article-title":"Azithromycin for prevention of exacerbations of COPD","volume":"365","author":"Albert","year":"2011","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1016\/j.carbpol.2024.122930_bb0015","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s42452-019-0237-6","article-title":"A rapid, developed and validated RP-HPLC method for determination of azithromycin","volume":"1","author":"Al-Hakkani","year":"2019","journal-title":"SN Applied Sciences"},{"issue":"3","key":"10.1016\/j.carbpol.2024.122930_bb0020","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s13346-022-01251-1","article-title":"Pulmonary drug delivery: An effective and convenient delivery route to combat COVID-19","volume":"13","author":"Alipour","year":"2023","journal-title":"Drug Delivery and Translational Research"},{"issue":"4","key":"10.1016\/j.carbpol.2024.122930_bb0025","doi-asserted-by":"crossref","first-page":"12","DOI":"10.22159\/ijap.2023v15i4.47644","article-title":"NANOTECHNOLOGY APPROACH-SELF NANOEMULSIFYING DRUG DELIVERY SYSTEM (SNEDDS)","volume":"15","author":"Annisa","year":"2023","journal-title":"International Journal of Applied Pharmaceutics"},{"key":"10.1016\/j.carbpol.2024.122930_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118543","article-title":"Dry powder formulation for pulmonary infections: Ciprofloxacin loaded in chitosan sub-micron particles generated by electrospray","volume":"273","author":"Arauzo","year":"2021","journal-title":"Carbohydrate Polymers"},{"issue":"12","key":"10.1016\/j.carbpol.2024.122930_bb0035","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.3390\/pharmaceutics13121988","article-title":"Excipient-free inhalable microparticles of azithromycin produced by electrospray: A novel approach to direct pulmonary delivery of antibiotics","volume":"13","author":"Arauzo","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.carbpol.2024.122930_bb0040","doi-asserted-by":"crossref","first-page":"13326","DOI":"10.1038\/s41598-023-40489-8","article-title":"Efficacy and safety of inhaled heparin in asthmatic and chronic obstructive pulmonary disease patients: A systematic review and a meta-analysis","volume":"13","author":"Ashmawy","year":"2023","journal-title":"Scientific Reports"},{"issue":"2","key":"10.1016\/j.carbpol.2024.122930_bb0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/jamp.2009.0745","article-title":"Inhalable lactose-based dry powder formulations of low molecular weight heparin","volume":"23","author":"Bai","year":"2010","journal-title":"Journal of Aerosol Medicine and Pulmonary Drug Delivery"},{"issue":"1","key":"10.1016\/j.carbpol.2024.122930_bb0050","doi-asserted-by":"crossref","first-page":"5207","DOI":"10.1038\/s41598-022-09133-9","article-title":"Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19","volume":"12","author":"Bai","year":"2022","journal-title":"Scientific Reports"},{"issue":"15","key":"10.1016\/j.carbpol.2024.122930_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22158064","article-title":"Manufacturing of 3D-printed microfluidic devices for the synthesis of drug-loaded liposomal formulations","volume":"22","author":"Ballacchino","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"4","key":"10.1016\/j.carbpol.2024.122930_bb0060","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.phrs.2012.06.011","article-title":"Anti-inflammatory mechanism of action of azithromycin in LPS-stimulated J774A. 1 cells","volume":"66","author":"Banjanac","year":"2012","journal-title":"Pharmacological Research"},{"issue":"52","key":"10.1016\/j.carbpol.2024.122930_bb0065","doi-asserted-by":"crossref","first-page":"33519","DOI":"10.1073\/pnas.2007626117","article-title":"Identification of novel targets of azithromycin activity against Pseudomonas aeruginosa grown in physiologically relevant media","volume":"117","author":"Belanger","year":"2020","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"8","key":"10.1016\/j.carbpol.2024.122930_bb0070","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3390\/pharmaceutics13081113","article-title":"Mannitol polymorphs as carrier in DPIs formulations: Isolation characterization and performance","volume":"13","author":"Benetti","year":"2021","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.carbpol.2024.122930_bb0075","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.it.2015.01.003","article-title":"Nitric oxide synthase in innate and adaptive immunity: An update","volume":"36","author":"Bogdan","year":"2015","journal-title":"Trends in Immunology"},{"key":"10.1016\/j.carbpol.2024.122930_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102969","article-title":"Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients","volume":"59","author":"Buijsers","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.carbpol.2024.122930_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11912-021-01125-8","article-title":"COVID and lung cancer","volume":"23","author":"Calabr\u00f2","year":"2021","journal-title":"Current Oncology Reports"},{"issue":"10","key":"10.1016\/j.carbpol.2024.122930_bb0090","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.3390\/jcm11102695","article-title":"Anticoagulant treatment in severe ARDS COVID-19 patients","volume":"11","author":"Ceccato","year":"2022","journal-title":"Journal of Clinical Medicine"},{"issue":"11","key":"10.1016\/j.carbpol.2024.122930_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15112601","article-title":"Co-delivery of a high dose of amphotericin B and Itraconazole by means of a dry powder inhaler formulation for the treatment of severe fungal pulmonary infections","volume":"15","author":"Celi","year":"2023","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.carbpol.2024.122930_bb0100","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.3390\/pharmaceutics15112601","article-title":"Co-delivery of a high dose of amphotericin B and Itraconazole by means of a dry powder inhaler formulation for the treatment of severe fungal pulmonary infections","volume":"15","author":"Celi","year":"2023","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.carbpol.2024.122930_bb0105","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ccm.2022.11.017","article-title":"Lung transplantation in coronavirus-19 patients: What we have learned so far","volume":"44","author":"Cerier","year":"2023","journal-title":"Clinics in Chest Medicine"},{"issue":"4","key":"10.1016\/j.carbpol.2024.122930_bb0110","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.cell.2020.09.033","article-title":"SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2","volume":"183","author":"Clausen","year":"2020","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.carbpol.2024.122930_bb0115","doi-asserted-by":"crossref","DOI":"10.7861\/clinmed.2020-0351","article-title":"Inhaled and systemic heparin as a repurposed direct antiviral drug for prevention and treatment of COVID-19","volume":"20","author":"Conzelmann","year":"2020","journal-title":"Clinical Medicine"},{"key":"10.1016\/j.carbpol.2024.122930_bb0120","unstructured":"COVID-19 Coronavirus Receptor Stable Cell Lines. Available at: https:\/\/www.genecopoeia.com\/product\/covid-19-coronavirus-stable-cell-lines\/. Accessed date: 8 June 2024."},{"issue":"3","key":"10.1016\/j.carbpol.2024.122930_bb0125","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.3390\/pharmaceutics15031023","article-title":"An enhanced dissolving Cyclosporin-a inhalable powder efficiently reduces SARS-CoV-2 infection in vitro","volume":"15","author":"D\u2019Angelo","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.carbpol.2024.122930_bb0130","doi-asserted-by":"crossref","unstructured":"Davidson, Ross J. (2019). In vitro activity and pharmacodynamic\/pharmacokinetic parameters of clarithromycin and azithromycin: why they matter in the treatment of respiratory tract infections. Infection and drug resistance:585\u2013596.","DOI":"10.2147\/IDR.S187226"},{"issue":"4","key":"10.1016\/j.carbpol.2024.122930_bb0135","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/17425247.2016.1224846","article-title":"Dry powder inhalation: Past, present and future","volume":"14","author":"de Boer","year":"2017","journal-title":"Expert Opinion on Drug Delivery"},{"key":"10.1016\/j.carbpol.2024.122930_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122788","article-title":"Targeting lung macrophages for fungal and parasitic pulmonary infections with innovative amphotericin B dry powder inhalers","volume":"635","author":"de Pablo","year":"2023","journal-title":"International Journal of Pharmaceutics"},{"issue":"22","key":"10.1016\/j.carbpol.2024.122930_bb0145","article-title":"Nebulised antibiotherapy: Conventional versus nanotechnology-based approaches, is targeting at a nano scale a difficult subject?","volume":"5","author":"de Pablo","year":"2017","journal-title":"Annals of translational medicine"},{"issue":"5","key":"10.1016\/j.carbpol.2024.122930_bb0150","first-page":"424","article-title":"Enoxaparin versus unfractionated heparin for venous thromboembolism prophylaxis in renally impaired ICU patients. Pharmacotherapy: The journal of human pharmacology and drug","volume":"41","author":"DeBiase","year":"2021","journal-title":"Therapy"},{"issue":"6","key":"10.1016\/j.carbpol.2024.122930_bb0155","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02558-22","article-title":"Inhalation of low molecular weight heparins as prophylaxis against SARS-CoV-2","volume":"13","author":"Eder","year":"2022","journal-title":"Mbio"},{"key":"10.1016\/j.carbpol.2024.122930_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.120167","article-title":"The diverse role of heparan sulfate and other GAGs in SARS-CoV-2 infections and therapeutics","volume":"299","author":"Eilts","year":"2023","journal-title":"Carbohydrate Polymers"},{"key":"10.1016\/j.carbpol.2024.122930_bb0165","doi-asserted-by":"crossref","unstructured":"Erelel, M, et al. 2021 Early Effects of Low Molecular Weight Heparin Therapy with Soft-Mist Inhaler for COVID-19-Induced Hypoxemia: A Phase IIb Trial. Pharmaceutics 2021, 13, 1768: s Note: MDPI stays neu-tral with regard to jurisdictional claims in \u2026.","DOI":"10.3390\/pharmaceutics13111768"},{"issue":"9","key":"10.1016\/j.carbpol.2024.122930_bb0170","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.3390\/ph16091254","article-title":"Non-anticoagulant activities of low molecular weight heparins\u2014A review","volume":"16","author":"Feng","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.carbpol.2024.122930_bb0175","doi-asserted-by":"crossref","unstructured":"Ferrand, R, et al. 2020 Effect of once-weekly azithromycin vs placebo in children with HIV-associated chronic lung disease: The BREATHE randomized clinical trial. JAMA Netw open2020; 3. doi:https:\/\/doi.org\/10.1001\/jamanetworkopen.","DOI":"10.1001\/jamanetworkopen.2020.28484"},{"issue":"3","key":"10.1016\/j.carbpol.2024.122930_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21926\/obm.transplant.2303193","article-title":"Lung transplantation for COVID-19 related lung disease: A follow-up study of outcomes from a medium-size lung transplant Programd","volume":"7","author":"Franco-Palacios","year":"2023","journal-title":"OBM Transplantation"},{"key":"10.1016\/j.carbpol.2024.122930_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2024.122268","article-title":"The study of galactomannans with different molecular weights and their ability to form microparticles suitable for pulmonary delivery","volume":"339","author":"Galrinho","year":"2024","journal-title":"Carbohydrate Polymers"},{"issue":"11","key":"10.1016\/j.carbpol.2024.122930_bb0190","doi-asserted-by":"crossref","DOI":"10.1099\/mgen.0.000454","article-title":"Azithromycin resistance mutations in Streptococcus pneumoniae as revealed by a chemogenomic screen","volume":"6","author":"Gingras","year":"2020","journal-title":"Microbial Genomics"},{"key":"10.1016\/j.carbpol.2024.122930_bb0195","unstructured":"guidelines, Clinical Laboratory Standards Institute (CLSI) minimum inhibitory concentration (MIC) Vol. 2024."},{"key":"10.1016\/j.carbpol.2024.122930_bb0200","article-title":"Suspension electrospinning of azithromycin loaded nanofibers","volume":"88","author":"G\u00fcler","year":"2023","journal-title":"Journal of Drug Delivery Science and Technology"},{"issue":"3","key":"10.1016\/j.carbpol.2024.122930_bb0205","doi-asserted-by":"crossref","first-page":"222","DOI":"10.5005\/jp-journals-10071-24420","article-title":"Nebulized heparin to reduce COVID-19-induced acute lung injury: A prospective observational study","volume":"27","author":"Gupta","year":"2023","journal-title":"Indian Journal of Critical Care Medicine: Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine"},{"key":"10.1016\/j.carbpol.2024.122930_bb0210","first-page":"1","article-title":"Nebulised heparin as a treatment for COVID-19: Scientific rationale and a call for randomised evidence","volume":"24","author":"Haren","year":"2020","journal-title":"Critical Care"},{"issue":"2","key":"10.1016\/j.carbpol.2024.122930_bb0215","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1124\/pharmrev.122.000684","article-title":"Pharmacology of heparin and related drugs: An update","volume":"75","author":"Hogwood","year":"2023","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.carbpol.2024.122930_bb0220","article-title":"Clinical efficacy and in vitro drug sensitivity test results of azithromycin combined with other antimicrobial therapies in the treatment of mdr p","volume":"13","author":"Huang","year":"2022","journal-title":"Aeruginosa ventilator-associated pneumonia. Frontiers in Pharmacology"},{"issue":"9","key":"10.1016\/j.carbpol.2024.122930_bb0225","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1097\/CCM.0000000000004458","article-title":"Coagulopathy of coronavirus disease 2019","volume":"48","author":"Iba","year":"2020","journal-title":"Critical Care Medicine"},{"issue":"5","key":"10.1016\/j.carbpol.2024.122930_bb0230","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3390\/pharmaceutics13050733","article-title":"Seaweed sulfated polysaccharides against respiratory viral infections","volume":"13","author":"Jabeen","year":"2021","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.carbpol.2024.122930_bb0235","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0732-8893(94)90027-2","article-title":"Validation of NCCLS macrolide (azithromycin, clarithromycin, and erythromycin) interpretive criteria for Haemophilus influenzae tested with the Haemophilus test medium","volume":"18","author":"Jones","year":"1994","journal-title":"Diagnostic Microbiology and Infectious Disease"},{"key":"10.1016\/j.carbpol.2024.122930_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.957598","article-title":"Effect of chronic lung diseases on mortality of prevariant COVID-19 pneumonia patients","volume":"9","author":"Kilic","year":"2022","journal-title":"Frontiers in Medicine"},{"key":"10.1016\/j.carbpol.2024.122930_bb0245","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.603151","article-title":"Azithromycin exhibits activity against Pseudomonas aeruginosa in chronic rat lung infection model","volume":"12","author":"Kumar","year":"2021","journal-title":"Frontiers in Microbiology"},{"key":"10.1016\/j.carbpol.2024.122930_bb0250","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3389\/fimmu.2016.00499","article-title":"Azithromycin attenuates Pseudomonas-induced lung inflammation by targeting bacterial proteins secreted in the cultured medium","volume":"7","author":"Leal","year":"2016","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.carbpol.2024.122930_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118526","article-title":"Recent advances in antiviral activities and potential mechanisms of sulfated polysaccharides","volume":"272","author":"Lu","year":"2021","journal-title":"Carbohydrate Polymers"},{"key":"10.1016\/j.carbpol.2024.122930_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-017-2334-9","article-title":"Physico-chemical properties, aerosolization and dissolution of co-spray dried azithromycin particles with l-leucine for inhalation","volume":"35","author":"Mangal","year":"2018","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.carbpol.2024.122930_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-018-2527-x","article-title":"Understanding the impacts of surface compositions on the in-vitro dissolution and aerosolization of co-spray-dried composite powder formulations for inhalation","volume":"36","author":"Mangal","year":"2019","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.carbpol.2024.122930_bb0270","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1007\/s13346-017-0462-8","article-title":"Agglomerated novel spray-dried lactose-leucine tailored as a carrier to enhance the aerosolization performance of salbutamol sulfate from DPI formulations","volume":"8","author":"Molina","year":"2018","journal-title":"Drug Delivery and Translational Research"},{"issue":"4","key":"10.1016\/j.carbpol.2024.122930_bb0275","doi-asserted-by":"crossref","first-page":"S290","DOI":"10.1016\/j.healun.2022.01.713","article-title":"Effects of azithromycin in lung transplant recipients","volume":"41","author":"Morlacchi","year":"2022","journal-title":"The Journal of Heart and Lung Transplantation"},{"issue":"2","key":"10.1016\/j.carbpol.2024.122930_bb0280","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2163","article-title":"Azithromycin in viral infections","volume":"31","author":"Oliver","year":"2021","journal-title":"Reviews in Medical Virology"},{"key":"10.1016\/j.carbpol.2024.122930_bb0285","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.cmi.2023.03.008","article-title":"COVID-19-associated mucormycosis: A systematic review and meta-analysis of 958 cases","volume":"6","author":"\u00d6zbek","year":"2023","journal-title":"Clinical Microbiology and Infection"},{"key":"10.1016\/j.carbpol.2024.122930_bb0290","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejps.2016.12.030","article-title":"Analgesic and anti-inflammatory controlled-released injectable microemulsion: Pseudo-ternary phase diagrams, in vitro, ex vivo and in vivo evaluation","volume":"101","author":"Pineros","year":"2017","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.carbpol.2024.122930_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.119551","article-title":"A state-of-the-art review on fucoidan as an antiviral agent to combat viral infections","volume":"291","author":"Pradhan","year":"2022","journal-title":"Carbohydrate Polymers"},{"key":"10.1016\/j.carbpol.2024.122930_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111561","article-title":"Pharmacological and clinical application of heparin progress: An essential drug for modern medicine","volume":"139","author":"Qiu","year":"2021","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"8","key":"10.1016\/j.carbpol.2024.122930_bb0305","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.3390\/ijms22084077","article-title":"Preparation and evaluation of a self-nanoemulsifying drug delivery system loaded with heparin phospholipid complex","volume":"22","author":"Qiu","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.carbpol.2024.122930_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40199-016-0153-x","article-title":"High azithromycin concentration in lungs by way of bovine serum albumin microspheres as targeted drug delivery: Lung targeting efficiency in albino mice","volume":"24","author":"Ramaiah","year":"2016","journal-title":"DARU Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.carbpol.2024.122930_bb0315","series-title":"Compendium of histology: A theoretical and practical guide","first-page":"351","article-title":"The respiratory system","author":"Rehfeld","year":"2017"},{"issue":"11","key":"10.1016\/j.carbpol.2024.122930_bb0320","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.3390\/pharmaceutics14112380","article-title":"Current treatments for COVID-19: Application of supercritical fluids in the manufacturing of Oral and pulmonary formulations","volume":"14","author":"Ruiz","year":"2022","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.carbpol.2024.122930_bb0325","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1208\/s12249-017-0767-4","article-title":"A new role of fine excipient materials in carrier-based dry powder inhalation mixtures: Effect on deagglomeration of drug particles during mixing revealed","volume":"18","author":"Shalash","year":"2017","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"10.1016\/j.carbpol.2024.122930_bb0330","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3390\/pharmaceutics15020674","article-title":"Impact of leucine and magnesium stearate on the physicochemical properties and aerosolization behavior of wet milled inhalable ibuprofen microparticles for developing dry powder inhaler formulation","volume":"15","author":"Sharif","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.carbpol.2024.122930_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.117232","article-title":"Comprehensive landscape of heparin therapy for COVID-19","volume":"254","author":"Shi","year":"2021","journal-title":"Carbohydrate Polymers"},{"key":"10.1016\/j.carbpol.2024.122930_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2024.121884","article-title":"Fucoidan from Ascophyllum nodosum and Undaria pinnatifida attenuate SARS-CoV-2 infection in vitro and in vivo by suppressing ACE2 and alleviating inflammation","volume":"332","author":"Shi","year":"2024","journal-title":"Carbohydrate Polymers"},{"issue":"6","key":"10.1016\/j.carbpol.2024.122930_bb0345","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/03639040701657552","article-title":"The spray drying of unfractionated heparin: Optimization of the operating parameters","volume":"34","author":"Shur","year":"2008","journal-title":"Drug Development and Industrial Pharmacy"},{"issue":"11","key":"10.1016\/j.carbpol.2024.122930_bb0350","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1002\/jps.21362","article-title":"Cospray-dried unfractionated heparin with L-leucine as a dry powder inhaler mucolytic for cystic fibrosis therapy","volume":"97","author":"Shur","year":"2008","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.carbpol.2024.122930_bb0355","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.coph.2018.01.006","article-title":"Therapeutic use of heparin and derivatives beyond anticoagulation in patients with bronchial asthma or COPD","volume":"40","author":"Shute","year":"2018","journal-title":"Current Opinion in Pharmacology"},{"issue":"4","key":"10.1016\/j.carbpol.2024.122930_bb0360","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3390\/ph16040584","article-title":"Heparin, low molecular weight heparin, and non-anticoagulant derivatives for the treatment of inflammatory lung disease","volume":"16","author":"Shute","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"7","key":"10.1016\/j.carbpol.2024.122930_bb0365","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1021\/acs.molpharmaceut.8b00097","article-title":"Orally bioavailable and effective buparvaquone lipid-based nanomedicines for visceral leishmaniasis","volume":"15","author":"Smith","year":"2018","journal-title":"Molecular Pharmaceutics"},{"issue":"9","key":"10.1016\/j.carbpol.2024.122930_bb0370","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.3390\/biom14091078","article-title":"The preventive and therapeutic effects of acute and severe inflammatory disorders with heparin and heparinoid","volume":"14","author":"Song","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.carbpol.2024.122930_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2024.122156","article-title":"Seaweed-derived fucoidans and rhamnan sulfates serve as potent anti-SARS-CoV-2 agents with potential for prophylaxis","volume":"337","author":"Song","year":"2024","journal-title":"Carbohydrate Polymers"},{"key":"10.1016\/j.carbpol.2024.122930_bb0380","doi-asserted-by":"crossref","first-page":"1154391","DOI":"10.3389\/frans.2023.1154391","article-title":"Heparin increases the antibiotic efficacy of colistin","volume":"3","author":"Szekeres","year":"2023","journal-title":"Frontiers in Analytical Science"},{"key":"10.1016\/j.carbpol.2024.122930_bb0385","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2016.00317","article-title":"PA3297 counteracts antimicrobial effects of azithromycin in Pseudomonas aeruginosa","volume":"7","author":"Tan","year":"2016","journal-title":"Frontiers in Microbiology"},{"key":"10.1016\/j.carbpol.2024.122930_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.119500","article-title":"Chitosan and its derivatives as polymeric anti-viral therapeutics and potential anti-SARS-CoV-2 nanomedicine","volume":"290","author":"Tan","year":"2022","journal-title":"Carbohydrate Polymers"},{"key":"10.1016\/j.carbpol.2024.122930_bb0395","article-title":"Effective inhibition of SARS-CoV-2 entry by heparin and enoxaparin derivatives","volume":"95(3):10.1128\/jvi","author":"Tandon","year":"2021","journal-title":"Journal of Virology"},{"issue":"1\u20132","key":"10.1016\/j.carbpol.2024.122930_bb0400","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ijpharm.2018.08.002","article-title":"3D printed drug products: Non-destructive dose verification using a rapid point-and-shoot approach","volume":"549","author":"Trenfield","year":"2018","journal-title":"International Journal of Pharmaceutics"},{"issue":"11","key":"10.1016\/j.carbpol.2024.122930_bb0405","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S1473-3099(18)30310-4","article-title":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990\u20132016: A systematic analysis for the global burden of disease study 2016","volume":"18","author":"Troeger","year":"2018","journal-title":"The Lancet Infectious Diseases"},{"key":"10.1016\/j.carbpol.2024.122930_bb0410","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s40256-020-00456-4","article-title":"Real-world comparative effectiveness and cost comparison of thromboprophylactic use of enoxaparin versus unfractionated heparin in 376,858 medically ill hospitalized US patients","volume":"21","author":"Veeranki","year":"2021","journal-title":"American Journal of Cardiovascular Drugs"},{"issue":"5","key":"10.1016\/j.carbpol.2024.122930_bb0415","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s11095-007-9475-1","article-title":"Pharmaceutical particle engineering via spray drying","volume":"25","author":"Vehring","year":"2008","journal-title":"Pharmaceutical Research"},{"issue":"22","key":"10.1016\/j.carbpol.2024.122930_bb0420","doi-asserted-by":"crossref","first-page":"15614","DOI":"10.1074\/jbc.M112.443507","article-title":"The choline-binding protein PspC of Streptococcus pneumoniae interacts with the C-terminal heparin-binding domain of vitronectin","volume":"288","author":"Voss","year":"2013","journal-title":"Journal of Biological Chemistry"},{"issue":"7","key":"10.1016\/j.carbpol.2024.122930_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.102203","article-title":"Effects of inflammation on thrombosis and outcomes in COVID-19: Secondary analysis of the ATTACC\/ACTIV-4a trial","volume":"7","author":"Walborn","year":"2023","journal-title":"Research and Practice in Thrombosis and Haemostasis"},{"issue":"1","key":"10.1016\/j.carbpol.2024.122930_bb0430","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12931-022-02007-8","article-title":"Efficacy, dose\u2013response, and aerosol delivery of dry powder synthetic lung surfactant treatment in surfactant-deficient rabbits and premature lambs","volume":"23","author":"Walther","year":"2022","journal-title":"Respiratory Research"},{"key":"10.1016\/j.carbpol.2024.122930_bb0435","doi-asserted-by":"crossref","first-page":"1190912","DOI":"10.3389\/fnut.2023.1190912","article-title":"Enhancing bioavailability of natural extracts for nutritional applications through dry powder inhalers (DPI) spray drying: Technological advancements and future directions","volume":"10","author":"Wang","year":"2023","journal-title":"Frontiers in Nutrition"},{"key":"10.1016\/j.carbpol.2024.122930_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2023.120628","article-title":"ROS-sensitive Crocin-loaded chitosan microspheres for lung targeting and attenuation of radiation-induced lung injury","volume":"307","author":"Wang","year":"2023","journal-title":"Carbohydrate Polymers"},{"key":"10.1016\/j.carbpol.2024.122930_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.119818","article-title":"Heparin: An old drug for new clinical applications","volume":"295","author":"Wang","year":"2022","journal-title":"Carbohydrate Polymers"},{"issue":"3","key":"10.1016\/j.carbpol.2024.122930_bb0450","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3233\/CH-221635","article-title":"The efficacy of low molecular weight heparin is reduced in COVID-19","volume":"84","author":"Watson","year":"2023","journal-title":"Clinical Hemorheology and Microcirculation"},{"key":"10.1016\/j.carbpol.2024.122930_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122024","article-title":"Validation of a cell integrated next-generation impactor to assess in vitro drug transport of physiologically relevant aerosolised particles","volume":"624","author":"Wong","year":"2022","journal-title":"International Journal of Pharmaceutics"},{"issue":"10","key":"10.1016\/j.carbpol.2024.122930_bb0460","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3109\/01902148.2010.492895","article-title":"Azithromycin reduces pulmonary fibrosis in a bleomycin mouse model","volume":"36","author":"Wuyts","year":"2010","journal-title":"Experimental Lung Research"},{"issue":"6523","key":"10.1016\/j.carbpol.2024.122930_bb0465","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1126\/science.abe4747","article-title":"Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2","volume":"370","author":"Xiang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.carbpol.2024.122930_bb0470","doi-asserted-by":"crossref","DOI":"10.3389\/fddev.2022.945459","article-title":"Inhalable composite microparticles containing siRNA-loaded lipid-polymer hybrid nanoparticles: Saccharides and leucine preserve aerosol performance and long-term physical stability","volume":"2","author":"Xu","year":"2022","journal-title":"Frontiers in Drug Delivery"},{"issue":"8","key":"10.1016\/j.carbpol.2024.122930_bb0475","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.carbpol.2024.122930_bb0480","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3389\/fimmu.2018.00302","article-title":"The immunomodulatory effects of macrolides\u2014A systematic review of the underlying mechanisms","volume":"9","author":"Zimmermann","year":"2018","journal-title":"Frontiers in Immunology"}],"container-title":["Carbohydrate Polymers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0144861724011561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0144861724011561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T17:10:04Z","timestamp":1731949804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0144861724011561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":96,"alternative-id":["S0144861724011561"],"URL":"https:\/\/doi.org\/10.1016\/j.carbpol.2024.122930","relation":{},"ISSN":["0144-8617"],"issn-type":[{"value":"0144-8617","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heparin-azithromycin microparticles show anti-inflammatory effects and inhibit SARS-CoV-2 and bacterial pathogens associated to lung infections","name":"articletitle","label":"Article Title"},{"value":"Carbohydrate Polymers","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carbpol.2024.122930","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"122930"}}